Related Experiment Video
Updated: Mar 23, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Spinal antinflammatory action of Diclofenac
1Department of Surgical Sciences, University of Turin, Turin, Italy - sandri.alberto@gmail.com.
Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), effectively treats chronic inflammatory pain. Its unique properties, including PPAR-γ activation and K+ channel blockage, enhance its efficacy in spinal nociception and neuro-inflammatory pain.
Area of Science:
- Pharmacology
- Neuroscience
- Rheumatology
Background:
- Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) used for chronic inflammatory pain conditions.
- Conditions treated include rheumatic diseases like rheumatoid arthritis and osteoarthritis, as well as periarthritis, bursitis, tendonitis, myositis, and sciatica.
Purpose of the Study:
- To elucidate the unique properties of diclofenac contributing to its enhanced efficacy.
- To investigate the mechanisms behind diclofenac's effectiveness in spinal nociception and chronic neuro-inflammatory pain.
Main Methods:
- The study focuses on the pharmacological mechanisms of diclofenac.
- Key mechanisms investigated include synergistic effects on peroxisome proliferator-activated receptor-γ (PPAR-γ) activation and prostaglandin synthesis inhibition (COX-2 inhibition).
- Neuronal K+ channel blockage and blood-brain barrier penetration were also examined.
Main Results:
- Diclofenac exhibits synergistic effects with PPAR-γ activation and COX-2 inhibition.
- It suppresses neuronal hyperexcitability by blocking neuronal K+ channels in a concentration-dependent manner.
- Diclofenac readily crosses the blood-brain barrier, contributing to its central effects.
Conclusions:
- Diclofenac's unique pharmacological profile, including its action on PPAR-γ, COX-2, and neuronal K+ channels, underlies its potent anti-inflammatory and analgesic effects.
- Its ability to penetrate the blood-brain barrier enhances its efficacy in treating central pain mechanisms.
- These properties differentiate diclofenac from other NSAIDs in managing chronic inflammatory pain.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
06:54Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
Published on: November 15, 2024
Related Concept Videos
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Local Anesthetics: Clinical Application as Spinal Anesthesia
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...